Kaiser Permanente of the Mid-Atlantic States was awarded the 2018 James A. Vohs Regional Quality Award for our Hepatitis C Pathway*. Currently, about 3.5 million people in the United States are living with hepatitis C (HCV) and roughly half are unaware of their infection. Left untreated, chronic hepatitis C can cause serious health problems, including liver damage, cirrhosis (scarring of the liver), liver cancer, and even death.
KPMAS developed a comprehensive pathway to improve screening, diagnosis and triage to treatment by leveraging technology to improve timely care coordination. Since implementation, total HCV testing has doubled, and screening among baby boomers (a high-risk group) has grown from 21 to 60 percent. Your support of preventive care programs like the Hepatitis C Pathway has improved quality and patient care.
You can learn more about our Hepatitis C Pathway in HealthConnect at .HCVPathway and view a short video the showcases our award winning program here or watch the video directly below:
*The James A. Vohs quality award was created to honor the contributions of James A. Vohs and is presented by the Kaiser Foundation Health Plan, Inc. and Hospitals Board of Directors annually.
Special thanks to: Adult & Family Medicine, Gastroenterology, Infectious Disease, Laboratory staff, TITER team, MGOS
